Events and Presentations

The ATMP Sweden conference is Sweden’s premiere annual conference bringing together ATMP stakeholders from pre-clinical research to reimbursement and standard of care. This will be our 5th physical annual conference. For 2024, its a 2 day event and expected at least 500 registrants.

This year, the 7th annual BioStock Summit will be extended with a pre-event Bootcamp Day tailored specifically to company executives who want to gain new insights and receive strategic advice from industry experts on highly relevant issues.

Company presentation

Partnering and networking event

CSO, Magnus Essand, has been invited to hold a presentation under the titel: Arming CAR T cells for potent bystander anti-tumor immune responses

Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. 

An arena for pitching groundbreaking innovations and business cases to a relevant audience of private investors, business angels, family offices, funds and venture capital portfolio managers with a keen interest in life science.

Forskningschef, Magnus Essand, har blivit inbjuden att hålla en muntlig presentation om iTANK och bolagets CAR T-program. 

After six long-awaited years, the ISCT Europe Region and its leadership are excited to welcome you to Gothenburg, Sweden and bring together our expansive network of CGT professionals to address topics and current challenges to drive the field forward and break down barriers to enable greater access to patients. 

Company presentation held at Biostock's global forum. The Global Forum brings together C-level management, BoD representatives with specialised investors and business developers seeking to expand personal networks and gain insights on key geographical regions in Europe, the USA and Asia.

Margareth Jorvid, board member of Elicera Therapeutics, will participate in a networking session to present the company's scientific abstract entitled "The iTANK platform has potential to improve CAR-T cell treatment of solid tumors". ISCT brings together leading researchers, clinicians and industry experts in cell and gene therapy from around the world. The main purpose of the conference is to promote the exchange of new scientific advances, technological advances and clinical insights in the rapidly developing field of cell and gene therapy

Scandinavian Society of Neuro-oncology (SNOG) was established in 1980s with the overall aim to increase communication between Scandinavian neuro-oncology experts, including both basic scientists and clinicians. One important aim of SNOG is to facilitate new collaborations and improve those already established. The SNOG meeting is an excellent arena to exchange ideas, and this is the key event organized by the society. Elicera's CSO, Magnus Essand, will present iTANK-data from the publication in Nature Biomedical Engineering along with ELC-401 data from the publication in Nature Communications. In addition, professor Essand will also present the synopsis for future potential clinical study with CAR T-cell therapy, ELC-401, in treatment of glioblastoma.

BIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings.

Company presentation at 09:45 at Wallenberg Conference Centre at Sahlgrenska Universitetssjukhuset in Göteborg. The presentation can also be seen live by web. 

Elicera's CEO, Jamal El-Mosleh, will present the Company on two occasions. The first occasion is on Wednesday, February 28th, at 4:00 PM and will be held digitally via Microsoft Teams. The second occasion is on Thursday, February 29th, at 12:00 PM and will be held at Mangold Fondkommission’s premises at Nybrogatan 55, where lunch will also be provided. Do note that both meetings will be held in Swedish. To participate in any of Elicera's investor meetings, please register by sending an email to corporate-finance@mangold.se no later than 3:00 PM on February 27th, 2024.

Elicera participates in a two-day conference in Uppsala on the topic of ATMP where CSO Magnus Essand among other things will hold a company presentation. 

BIO-Europe convenes over 5,500 attendees, representing 60 countries and 2,220+ companies, making the event the industry's largest gathering of biopharma professionals in Europe.

Company presentation at 13:45 CET. 

INTERNATIONAL PARTNERING, STRATEGY & INVESTMENT FOR NORDIC LIFE SCIENCE EXECUTIVE LEADERS

Company presentation 14.20-14.55. 

Company presentation at 11.30. 

Largest event held by Erik Penser Bank. Time and place: May, 25, 2023. Place: Haymarket by Scandic in Stockholm Time: Ca 09:00-17:00 CET

Company presentation. 

Company presentation that can be seen on the link below. 

Partnering event. 

Company presentation at 11.45 CET. 

The presentation can be followed live in the link below. 

Our CEO will present Elicera and the iTANK-platform at the CAR-TCR Summit Europe in London. 

Head of translational research at Elicera, Di Yu, to present the iTANK-platform and ELC-201 on December 7 at 9:00 am EDT. 

Company presentation

Company presentation 10:30-11:00. 

Partnering event. 

Elicera is sponsoring this event focusing on engineering strategies to delivering safe and effective adoptive cell therapy products to clinical promise, commercial scale manufacturing and patients. CEO, Jamal El-Mosleh, to present the iTANK-platform on November 2 at 15:55 CET. 

Partner event in Malmö. 

Place: 7A Posthuset, Vasagatan 28 in Stockholm

Elicera is sponsoring this event focusing on engineering strategies to deliver persistent, efficacious, safe cell therapy products. Senior Scientist, Tina Sarén, to present the iTANK-platform on August 22 at 1:50 pm EDT and participate in a panel discussion. 

The Nordic Health Summit Japan is a partnering and investor conference aimed at connecting Nordic healthcare innovations with Japanese investors, industry and ecosystems. We invite innovative Nordic health tech and Life Science companies to explore partnerships with Japanese stakeholders including pharmaceutical companies, investors and medical device companies eager to connect with the Nordics.

Elicera participates in partnering conference. 

SWECARNET, Sweden’s network for clinical use of CAR T-cells, will hold an Educational Day on April 27th, 2022, where Elicera’s CSO, Professor Magnus Essand, will hold a presentation on the topic: What will reseach bring in the future? More information and the program can be found here: https://atmpsweden.se/events/swecarnet-utbildningsdag-2022/ Registration can be done here: https://www.eventbrite.com/e/swecarnet-utbildningsdag-biljetter-265001345157

Elicera participates in partnering conference. 

We will participate at Redeye Theme: Regenerative Medicine / Cell Therapy on 23 February Our CEO presents at 09:30 CET. 

CEO presents at HC Andersen at 11.00 CET. 

See our CEO present the company in the link below:

See the company presentation (in Swedish) in the link below: 

Company presentation 13:00-13:30 CET.

Company presentation at 11:30. See the presentation in the link below. 

Returning for its sixth year, LSX’s Inv€$tival Showcase directly connects life science corporates to global capital and partners. An international showcase of early, growth stage and public life science and health technology companies, Inv€$tival ShowcaseTM provides an unrivalled opportunity to pitch, profile and connect with investors and partners brought together during the biggest fortnight in European life sciences investment. The company showcases will highlight and promote the most exciting and innovative biotech, medtech, health technology and consumer health companies across Europe and beyond.

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. Nearly 1,300 delegates from 40 countries, including 75% from pharma and biotech organizations, last convened in-person in Lisbon in 2019 to discuss the latest advances in protein and antibody engineering.

DI Yu will present preclinical iTANK-data at an HC Andersen Capital Online event at 11.00 - 11.20. See the presentation below.

Elicera's Chief Development Officer, Dr Di Yu, will orally present preclinical proof-of-concept data for the company's iTANK platform during the upcoming ESGCT Collaborative Virtual Congress to be held on October 19-22, 2021. This is also the first time the iTANK platform will be publicly presented.

HC Andersen Capital holds a virtual life science event with focus on immunotherapy. 

CEO Jamal El-Mosleh holds a company presentation June 7th at 12.00 CET at HC Andersen Capital. 

Elicera's CEO, Jamal El-Mosleh, holds a company presentation at Biostock's Virtual Investor Pitch, May 31st at 10.00 CET. 

Elicera's CEO, Jamal El-Mosleh, holds a company presentation at Aktiespararnas event "Aktiedagen Göteborg" on May 17th at 11.30 CET. See the presentation in the link below. 

Elicera participates in LSX World Congress 2021 Virtual, an event for meetings with potential partners and investors. 

Elicera's CEO, Jamal El-Mosleh, holds a company presentation at "Investerarafton 27 januari" between 12.30-13.00. 

CEO Jamal El-Mosleh holds a company presentation. See the presentation on the link below.